123
Views
10
CrossRef citations to date
0
Altmetric
Articles

Degradation of recalcitrant phenol pollutant and antibacterial study by Ni, Sr doped ZnO

, &
Pages 114-123 | Received 25 Sep 2018, Accepted 24 Aug 2019, Published online: 16 Sep 2019
 

Abstract

The carcinogenic and toxic effect of phenol on living being is potentially non recoverable. So, in order to degrade phenol into its benign form, undoped ZnO and Ni, Sr doped ZnO photocatalysts were synthesized by a citrate gel method. The synthesized photocatalysts were characterized by different characterizing techniques such as TG-DTA, UV-Visible absorption analysis, XRD, EDX, FE-SEM etc. Photoluminescence spectra showed the blue shift which explains bulk defects that enhanced efficiency of photocatalyst. The effect of dopant concentration, catalyst loading and pH of solution has been studied. It was observed that, degradation efficiency of Ni0.02Sr0.08ZnO was found high than undoped ZnO. So, it is better alternative than undoped ZnO. The potential antibacterial activity of undoped ZnO and Ni, Sr doped ZnO nanoparticles were investigated using Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, S. Typhi as test organism and results showed doped ZnO is more active against bacteria than undoped ZnO.

Acknowledgements

The authors are extremely grateful to Department of Chemistry, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad, IIT, Mumbai and IIT, Madras.

Conflict of interests

The authors declare that there is no conflict of interest regarding the publication of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.